Karriereverlauf von Therésa K. Dixon
Ehemalige bekannte Positionen von Therésa K. Dixon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2014 | 01.02.2016 |
| Covance Health Economics & Outcomes Services, Inc. | Corporate Officer/Principal | - | - |
| SMITH & NEPHEW PLC | Corporate Officer/Principal | - | - |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Public Communications Contact | 24.11.2011 | - |
| General Counsel | 01.01.2007 | 24.11.2011 |
Ausbildung von Therésa K. Dixon
| University of Missouri | Undergraduate Degree |
| Marymount University | Graduate Degree |
| University of Maryland | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Public Communications Contact | 1 |
| General Counsel | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SMITH & NEPHEW PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
| Covance Health Economics & Outcomes Services, Inc. | |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
- Börse
- Insiders
- Therésa K. Dixon
- Erfahrung
